Ethylenediamine → N2-(5-{5-[(methylsulfonyl)amino]-1H-pyrrolo[2,3-b]pyridin-3-yl}pyridin-3-yl)-N-(2,2,2-trifluoroethyl)valinamide
Reaction equation
[CH3:1][S:2]([NH:5][C:6]1[CH:7]=[C:8]2[C:14]([C:15]3[CH:16]=[C:17]([NH:21][C@H:22]([C:26]([NH:28][CH2:29][C:30]([F:33])([F:32])[F:31])=[O:27])[CH:23]([CH3:25])[CH3:24])[CH:18]=[N:19][CH:20]=3)=[CH:13][N:12](COCC[Si](C)(C)C)[C:9]2=[N:10][CH:11]=1)(=[O:4])=[O:3].C(O)(C(F)(F)F)=O.C(N)CN.[OH-].[Na+]>C(Cl)Cl.CS(C)=O>[CH3:1][S:2]([NH:5][C:6]1[CH:7]=[C:8]2[C:14]([C:15]3[CH:16]=[C:17]([NH:21][C@H:22]([C:26]([NH:28][CH2:29][C:30]([F:33])([F:32])[F:31])=[O:27])[CH:23]([CH3:25])[CH3:24])[CH:18]=[N:19][CH:20]=3)=[CH:13][NH:12][C:9]2=[N:10][CH:11]=1)(=[O:4])=[O:3]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of N2-[5-(5-[(methylsulfonyl)amino]-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-3-yl]-N-(2,2,2-trifluoroethyl)valinamide 5-3a (57 mg, 0.093 mmol) from step 1 in DCM (2 mL) was added TFA (0.714 mL, 9.27 mmol) and the resultant mixture was stirred for 2 h. The mixture was concentrated in vacuo, resuspended in MeOH (1 mL) and to this was added ethylenediamine (0.013 mL, 0.185 mmol) and sodium hydroxide (10 M aq) (0.065 mL, 0.649 mmol). After 18 h, the reaction was transferred to vial with an additional 1 mL of dimethylsulfoxide and this solution was purified by mass triggered reverse phase HLPC. The fractions containing product 5-3 were basified with NaHCO3, dried over MgSO4, filtered and concentrated.
Workup
- concentrationThe mixture was concentrated in vacuo
- customthis solution was purified by mass triggered reverse phase HLPC
- additionThe fractions containing product 5-3
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-8213ef325dc742a481498f69a64a96b4
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09096598B2
Reaction notes
Loading…